What clinical and economic evidence do US payers prefer to drive formulary decisions? How can you optimise your chances of preferential access in the US with the right evidence? How...
Read More
How can real-world evidence (RWE) support health technology assessment (HTA)? Can real-world data (RWD) supplement clinical data? How can RWE be used to solve common challenges with treatment comparison? In...
Read More
How is the NHS preparing for winter? Which challenges are the most pressing for NHS decision-makers? How can industry best engage and support NHS decision-makers in the next few months?...
Read More
Discover how data visualisation dashboards can aid field teams in market access discussions with customers Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with...
Read More
Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a...
Read More
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...
Read More
What do you need to know about the market access and reimbursement landscape in Canada? What changes can we expect at the Canadian Agency for Drugs and Technologies in Health...
Read More
Where will you be launching your new orphan medicine? You may be confident that your Global market access strategy will support access in key launch markets like the UK, the...
Read More
Which decisions are made at Region level in the NHS in England? How do finances and funding work at this level? And how can industry best support and engage with...
Read More
What do we know about plans and policy for 2024/25? As the expected central operating plan has not (yet) materialised, and with a general election and a potential Labour government...
Read More
